Parkinson Disease: Functional Assessment, Gene Disruptions, and More
New Parkinson disease studies offer insights into topics such as LRRK2 G2019S transgene activity, preclinical drug development, and neuroprotection in Parkinson disease.
FDA Drug and Biologic Approvals for Neurology: 2017 Midyear Review
Seven new drugs were approved for treatment of neurological disorders, including Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis.
Neurology in the News: Migraine, Childhood Epilepsy, and More
New studies shed light on topics such as nonencephalic pain and headache chronicity; benign childhood epilepsy with centrotemporal spikes and social cognition; and causal triggers of Alzheimer disease onset.